General Archive
-
News releases
LifeArc and Scottish Government Chief Scientist Office launch new funding scheme to boost translational research in Scotland
Funding aims to progress strong discovery science to a point where additional substantive funding could be secured.
-
Articles & blogs
Celebrating the International Day of Women and Girls in Science
LifeArc celebrates the UN’s International day of Women and Girls in Science, joining the call to remove any barriers that…
-
News releases
LifeArc and Action Medical Research launch funding call for research into rare diseases in children
£1m for translational research projects focussed on children’s rare diseases
-
News releases
LifeArc appoints new Chief Investment Officer (CIO)
Graham Duce appointed to the newly created role of CIO to ensure that we have a sustainable approach to income…
-
News releases
Patients with ultra-rare bone marrow disease set to benefit from £1.15m grant from LifeArc and The Aplastic Anaemia Trust
A research grant to investigate the potential of a novel type of “personalised cellular therapy” to reverse the ultra-rare condition,…
-
News releases, Ventures funding
LifeArc Seed Fund makes £1.5million investment in Caldan Therapeutics to develop novel treatments for metabolic diseases
Investment to allow Caldan to translate work on free fatty acid receptors initiated in their laboratories
-
News releases
Kymab and LifeArc enter strategic partnership to discover new medicines using Kymab’s IntelliSelect® technologies
The agreement will enable LifeArc to enhance our antibody drug discovery capabilities
-
Ventures funding, News releases
LifeArc invests £1.5 million in Ducentis BioTherapeutics
LifeArc’s Seed Fund has invested £1.5 million in Ducentis BioTherapeutics to develop novel drug therapies for inflammatory and autoimmune disease
-
News releases
LifeArc monetises Keytruda® royalty interests to fund further research and investment
LifeArc receives US$1.3bn for a portion of royalty interests in Keytruda (pembrolizumab), making us one of the UK’s leading medical…
-
News releases
Medicines Discovery Catapult and LifeArc launch strategic R&D partnership in biomarker discovery and proteomics technology
Three-year partnership to fund clinical application of biomarker strategies to help progress novel drug candidates to clinical evaluation stage
-
News releases
LifeArc and The University of Kent collaborate to develop potential pain medicines
Three-year programme will focus on ion channel drug discovery, to evaluate if small molecule modulators, optimised as part of the…
-
News releases
Cancer Research UK, Lifearc and Ono Pharma Form Cancer Immunotherapy Alliance
New immunotherapy drug targets for cancer will be progressed through a multimillion-pound drug discovery alliance announced today (Wednesday) between Cancer…